newsfilter
← Latest News
Business Wire·

Aptorum Group Announces Offering of $3 Million Convertible Note due 2023

Regulatory News: Aptorum Group Limited (NASDAQ:APM, PARIS:APM) ("Aptorum Group" or "Aptorum"), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and